Your web browser is out of date! We recommend you update your browser to receive the best possible browsing experience.
Download your Brochure
Purchase Now

Your stakeholders are key – satisfy all their needs at North America's leading market access and real-world evidence summit.


Meeting the needs of payers, patients and decision-makers is a must for any successful pharma company!

At Data, Evidence and Access Summit 2017 (Nov 13-14) we know that demonstrating and communicating value is key, no matter which department you’re in. Whether it’s exploring innovative uses of real-world evidence (RWE) or creating new outcomes-based pricing models, only by embracing the power of data can you fully unlock the value of your drugs.

Don’t miss the opportunity to meet the industry’s leading market access and RWE experts.

Latest speakers to join the line-up: 

Debbie Drane
Debbie Drane

CSL Behring

SVP Commercial Development

Holly Krasa
Holly Krasa

Otsuka

Senior Director, Health Outcomes

Joseph Dye
Joseph Dye

UCB

Head of HEOR, Neurology US

Gergana Zlateva
Gergana Zlateva

Pfizer

Vice President, Oncology Market Access

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Key agenda sections:

Keynotes
12:00 - 12:30

Navigate your way turbulent healthcare landscape, unlock the meaning of true value for your key stakeholders and witness the future of evidence generation.

12:00 - 12:30
Real-world data
12:00 - 12:30

The latest from the FDA & payers, how RWE is transforming development and the next-gen technologies revolutionising data generation and analytical capabilities.

12:00 - 12:30
Market Access
12:00 - 12:30

Prioritise access throughout your organisation, create real value with innovative pricing schemes and prepare your portfolio for value based agreements.

Snapshot of our presenters:

Sandy Leonard
Sandy Leonard

AstraZeneca

Vice President, Medical Evidence and Observational Research

Peter Juhn
Peter Juhn

Amgen

Vice President and Global Head of Value-based Partnerships

Jonathan Jarow
Jonathan Jarow

FDA

Senior Medical Director

Ana Cespedes
Ana Cespedes

Merck KGaA

SVP & Project Lead, Core competencies for the future of Merck KGaA Healthcare business, Global Marketing & Strategy

Riccardo Perfetti
Riccardo Perfetti

Sanofi

Senior Medical Officer, Vice President Global Medical Affairs, Diabetes Division

Karthik Ramakrishnan
Karthik Ramakrishnan

TEVA

Senior Manager, GHEOR

Ken Carson
Ken Carson

Flatiron Health

Senior Medical Director

Margaret McDonald, PhD
Margaret McDonald, PhD

Pfizer

Senior Director, Real World Data and Analytics, Patient & Health Impact

Debbie Drane
Debbie Drane

CSL Behring

SVP Commercial Development

Edmund Pezalla
Edmund Pezalla

Aetna

Former Vice President for Pharmaceutical Policy and Strategy

Dr. Vidya Raman-Tangella
Vidya Raman-Tangella

UnitedHealthcare

SVP, Head Innovation Center of Excellence

Jack Sheehan
Jack Sheehan

Janssen

RWE Pragmatic Trial Team Lead

5 reasons to attend:

1

Crystal clarity. Gain 360-degree vision when navigating the complex US healthcare system – and slash time-to-market.

2

The real-world revolution. Ensure RWE is making its mark throughout your development process, from proof of concept to pragmatic trials

3

Know your value. Understand the true wishes of payers and other key stakeholders – and provide the evidence required to influence their decisions and boost your value proposition

4

Industry-saving pricing models. How outcomes-based agreements can help guarantee reimbursement during times of rising costs and tightening budgets

5

Stakeholders are the key. Why speculate when you can collaborate directly with key payers, FDA and other key influencers, all under one roof?

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

Some of the industry leading companies already involved:

abbvie
aetna
amgen
astellas
astra_zeneca
boston_health_economics
bms
bayer
clover_health
csl_behring
emd_serono__teal
sanofi
evidation_health
fda
genentech
novartis
ibm
icer
inc_research
janssen
lilly
united_healthcare
merck
nestle
huron
novo_nordisk
otsuka
parexel
pfizer
popewoodhead
ert
shyft_analytics
teva
ucb
meaning_cloud
zs_associates

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription

84% of our attendees call our sessions “essential” to their future success
98% rated the program very well run
94% of our attendees say that will likely return next year

What our delegates say:

Got a question? Get in touch below!

James Mackintosh

James Mackintosh

Global project Director | eyeforpharma

Email: jmackintosh@eyeforpharma.com

Phone (US): 1 800 814 3459 ext. 7163

Phone (Global): +44 (0) 207 375 7163

Ben Parkes

Ben Parkes

Head of Product | eyeforpharma

Email: bparkes@eyeforpharma.com

Phone (US): 1 800 814 3459 ext. 4346

Phone (UK): +44 (0) 207 422 4346

Purchase the Post-Conference Materials

Event Presentations • Event Audio • On Demand Subscription